Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neoplastic process that affects the squamous epithelium of the cervix. It is classified as cervical squamous intraepithelial neoplasia 1, 2, or 3, according to the degree of squamous cell maturation and cellular atypia, and the number of mitotic figures.
Biomarker and diagnostic research for cervical squamous intraepithelial neoplasia has been reported in the published literature.
3 clinical trials registered, 2 recruiting. Interventions under study include other interventions and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
142 publications have been identified in PubMed for cervical squamous intraepithelial neoplasia. Research spans Epidemiology / Natural History (25%), Diagnostic / Biomarker (23%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 36 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:50 AM UTC
25%
Testing and diagnosis research | 33 | 23% |
Laboratory research | 21 | 15% |
Clinical study results | 18 | 13% |
Research summaries | 16 | 11% |
Patient case studies | 16 | 11% |
New treatment approaches | 2 | 1% |
Jain MA (2026). [PMID: 32644501](https://pubmed.ncbi.nlm.nih.gov/32644501/). *Unknown Journal*. [Diagnostic / Biomarker]
Yang ST (2026). [PMID: 41617346](https://pubmed.ncbi.nlm.nih.gov/41617346/). *Taiwan J Obstet Gynecol*. [Clinical Trial Publication]
Khieu M (2026). [PMID: 28613479](https://pubmed.ncbi.nlm.nih.gov/28613479/). *Unknown Journal*. [Basic Science / Preclinical]
Ma Y (2026). [PMID: 41859136](https://pubmed.ncbi.nlm.nih.gov/41859136/). *Front Med (Lausanne)*. [Epidemiology / Natural History]
He J (2026). [PMID: 41457279](https://pubmed.ncbi.nlm.nih.gov/41457279/). *J Immunother*. [Gene Therapy / Novel Therapeutics]
Zhang G (2026). [PMID: 41997365](https://pubmed.ncbi.nlm.nih.gov/41997365/). *Lab Invest*. [Basic Science / Preclinical]
Matsukawa H (2026). [PMID: 41930639](https://pubmed.ncbi.nlm.nih.gov/41930639/). *Cancer Med*. [Diagnostic / Biomarker]
Gómez Cherey JF (2026). [PMID: 41444070](https://pubmed.ncbi.nlm.nih.gov/41444070/). *Rev Argent Microbiol*. [Epidemiology / Natural History]
Joura E (2026). [PMID: 41166720](https://pubmed.ncbi.nlm.nih.gov/41166720/). *Obstet Gynecol*. [Clinical Trial Publication]
Guan J (2026). [PMID: 41662430](https://pubmed.ncbi.nlm.nih.gov/41662430/). *J Infect Dev Ctries*. [Epidemiology / Natural History]